Topic: MS

ACTRIMS Forum 2026 survey

February 3, 2026  

PRL detected in optic chiasm

January 30, 2026  

BTK inhibitors – a look ahead

January 20, 2026  

High-efficacy DMTs for MS: the year in review

December 1, 2025  

Ocrelizumab use throughout the MS clinical course: highlights from ECTRIMS 2025

October 15, 2025  

Early use and long-term safety of ofatumumab: highlights from ECTRIMS 2025

October 7, 2025  

ECTRIMS 2025 HIGHLIGHTS – SATURDAY, SEPTEMBER 27, 2025

September 27, 2025  

ECTRIMS 2025 HIGHLIGHTS – FRIDAY, SEPTEMBER 26, 2025

September 26, 2025  

ECTRIMS 2025 HIGHLIGHTS – THURSDAY, SEPTEMBER 25, 2025

September 25, 2025  

ECTRIMS 2025 survey

September 4, 2025